Effects of Erythropoiesis-Stimulating Agents on Overall Survival of IPSS Low/INT-1 Risk Transfusion Independent Myelodysplastic Syndrome Patients, a FISM Study. (April 2017) - Messa, E.; Gioia, D.; Masiera, E.; Castiglione, A.; Ceccarelli, M.; Salvi, F.; Danise, P.; Sanna, A.; Allione, B.; Balleari, E.; Poloni, A.; Cametti, G.; et al.